Last Updated : December 9, 2024
Details
FilesGeneric Name:
naloxagol
Project Status:
Active
Therapeutic Area:
Management of opioid-induced constipation (OIC).
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0753-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
Treatment of opioid-induced constipation (OIC) in adult patients with cancer and non-cancer pain who have had an inadequate response to laxative(s).
| Submission received | November 22, 2024 |
|---|---|
| Expert committee meeting (initial) | May 15, 2025 |
Files
Last Updated : December 9, 2024